INTERNATIONAL PATENT: PRINCIPIA BIOPHARMA INC. FILES APPLICATION FOR "TREATMENT OF VENOUS THROMBOSIS WITH RILZABRUTINIB AND DERIVATIVES THEREOF"

GENEVA, Feb. 4 -- PRINCIPIA BIOPHARMA INC. (100 Morris StreetMorristown, New Jersey 07960) filed a patent application (PCT/US2025/038731) for "TREATMENT OF VENOUS THROMBOSIS WITH RILZABRUTINIB AND DERIVATIVES THEREOF" on Jul 22, 2025. With publication no. WO/2026/024765, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NICOLSON, Phillip L.R. (The University of BirminghamEdgbastonBirmingham B15 2TT), LANGRISH, Claire (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), THEODORE, Lindsay (c/o Sanofi...